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Alzheimer is a common disease that threatens the health
of the elderly [1-3]. Uncaria a member of the Rubiaceae
family, has long been used in traditional Chinese medicine
to treat hypertension, convulsions, tremor, and stroke [4].
Indole alkaloids present in aqueous solution have been
shown to interfere with fiber formation of β-amyloid
protein (Aβ) and destabilize preformed Aβ fibrils, a patho-
logical marker of Alzheimer’s disease [5]. An ethanol
extract of Uncaria was found to improve the cognitive
impairment of Alzheimer’s disease caused by D-galactose
in mice [6]. RIN and IRN two major alkaloid chemicals
that are synthesized in Uncaria capsules, can inhibit the
activation of microglia and reduce Aβ-induced death in
cell lines used to study neuronal differentiation (PC12) [7].
Also RIN reduces Aβ cytotoxicity by inhibiting intracellu-
lar calcium overloading and tau protein hyperphosphory-
lation [8,9]. Extracts from Uncaria have the potential
for delaying or alleviating the symptoms of Alzheimer’s
diseases that could significantly improve the quality of life
of patients.
RIN and IRN belong to TIAs. TIAs are a diverse class
of natural products that comprise over 2000 members,
many of which possess significant physiological activity.
Most TIAs are found in three dicotyledon plant families:
Apocynaceae, Rubiaceae and Loganiaceae, and are thought
to be part of a plants chemical defense against pests [10].
TIAs have a wide variety of different molecular structures
and biological activities [11]. Notable TIAs include vincris-
tine and vinblastine of Catharanthus roseus that have
anti-tumor activity. Vinblastine is clinically used for the
treatment of leukemia, Hodgkin’s lymphoma and other
cancers [12-15]. Ajmaline of Rauwolfia serpentina can
block the sodium channel and resist arrhythmia [15-17].
Whereas, Yohimbine is antagonist of α-2-adrenoceptor
and a potential drug for the treatment of erectile dysfunc-
tion [18,19]. Camptothecin of Ophiorrhiza pumila and
Camptotheca acuminata is a topoisomerase enzyme
inhibitor, and has anti-cancer effect [20,21]. Quinine of
Cinchona species is a known anti-malarial drug [22,23].
TIAs production in plants is generally low and difficult to
synthesize chemically, limiting the utility of these thera-
peutic chemicals unless production is increased by meta-
bolic engineering [11]. However, metabolic engineering
requires knowledge of the TIAs biosynthesis pathway
which is only well understood for a few, such as vindoline
and ajmaline.
TIAs biosynthesis involve multiple and complex metabolic
pathways. All TIAs are derived from tryptophan and seco-
loganin. Tryptophan decarboxylase (TDC; EC 4.1.1.28), a
pyridoxal dependent enzyme converts tryptophan to trypta-
mine. Isopentenyl diphosphate (IPP) the precursor for all
terpenoids is produced by the triose phosphate/pyruvate or
“non-mevalonate” pathway (MEP/DOXP pathway) [24,25].In the first committed step of iridoid terpene biosynthesis,
geraniol, derived from IPP, is hydroxylated by geraniol-10-
hydroxylase (G10H; EC 2.5.1.1) [26,27]. Oxidation of the
iridotrial aldehyde to the carboxylic acid is followed by
esterification and glucosylationto, yield deoxyloganin;
subsequent hydroxylation of deoxyloganin yields loganin.
Secologanin is then generated by oxidative cleavage of
loganin by the enzyme secologanin synthase (SLS; EC
1.3.3.9) [28-33]. Biosynthesis of secologanin is thought to
be potential rate-limiting step in TIAs biosynthesis. Trypta-
mine of tryptophan metabolic pathway via strictosidine
synthase (STR; EC 4.3.3.2) catalysis forms strictosidine [34],
and then enters TIAs biosynthetic pathway [35]. This part
of the synthesis processes is the best characterized, and the
genes encoding the enzymes are known. However each
individual TIAs has a synthetic branch, which is started at
strictosidine. Through four variable precursors, (4,21-Dehy
drogeissoschizine, cathenamine, 19-epi-cathenamine and
stemmadenine), each active substance enters the branch
path. From structural analysis of RIN and IRN, they may be
transformed from Stemmadenine (Figure 1). This specula-
tion is according to the up-stream pathway of TIAs synthe-
sis, which is the biosynthetic process of secologanin [36,37].
Stemmadenine synthesized RIN and IRN through the
chemical reactions of oxidation and methyl transfer. This
process requires three kinds of enzymes; oxidoreductases,
methyltransferases and isomerases. The genes coding for
oxidoreductases, methyltransferases and isomerases are
defined as “late step genes” of RIN and IRN biosynthesis.
Next generation sequencing technologies have proved
to be rapid and cost-effective means to analyze the
genome and transcriptome in non-model species. In this
study, knowledge of the rapid accumulation periods of
RIN and IRN in Uncaria was used to find potential can-
didates in the synthesis of these TIAs. Using transcrip-
tome sequencing, de novo assembly and DGE analysis,
candidate genes encoding putative enzymes responsible
for late steps in RIN and IRN synthesis were identified.
Our results lay a foundation for construction of the RIN
and IRN biosynthetic pathways that will in turn aid the
study of the regulation and metabolic engineering of
RIN and IRN biosynthesis.
Results
De novo transcriptome sequencing of capsule
We compared RIN and IRN content throughout the
development of Uncaria’s capsule, from fallen petal (desig-
nated capsule 1, sample point #1) to maturity (designated
capsule 3, sample point #5) (Figure 2). RIN and IRN con-
tent changed dramatically during the development of the
Uncaria capsule. The two TIAs accumulate in the cap-
sules were detected in capsule 1 (fallen petal), until a max-
imum is reached at sample point 3 (designated capsule 2)
20 days later, and then drops to its lowest levels at capsule
Figure 1 Putative rhynchophylline and isorhynchophylline biosynthesis pathway in Uncaria rhynchophylla. MEP pathway: “non-mevalonate”
pathway; TDC: tryptophan decarboxylase, EC:4.1.1.28; STR: strictosidine synthase, EC:4.3.3.2; P450: cytochrome P450, EC:1.14.-.-.
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(Figure 2). To obtain an overview of the Uncaria capsule
transcriptome in the process of RIN and IRN accumulation,
a cDNA library was generated from an equal mixture of
RNA isolated from capsule 1 (starting point for RIN and
IRN accumulation), capsule 2 (peak RIN and IRN content),
and capsule 3 (RIN and IRN content is at its lowest).
The library was sequenced using the Illumina HiSeq™
2000 platform. 51 million raw reads were obtained which
had 50,159,521 clean reads (97.49% of all raw reads) (in
Additional file 1: Table S1), which were used for all subse-
quent analysis.
With the increase of the sequencing length, sequencing
error rates will rise [38,39], but the error rate does not
exceed 1% (in Additional file 2: Figure S1). 6 bp random
primers were used in reverse transcription. The incomplete
binding of random primers and template could cause se-
quencing errors of the first six nucleotides position [39,40]
(in Additional file 2: Figure S1, S2). Clean reads were
spliced into transcripts by trinity software (v2012-10-05)
[41], and 100,940 transcripts were obtained. Transcript
length was an index which measured with splicing effect.
To a certain extent, N50 can evaluate splicing integrity
[42]. The average length of transcript was 1,181 bp, thelongest transcript was 14,101 bp, the shortest transcript
was 201 bp (N50 was 1970 bp, N90 was 503 bp). From
these transcripts, 55,523 unigenes were identified, with an
average length of 717 bp, the longest unigene was
13,307 bp, the shortest unigene 201 bp (N50 was 1242 bp,
N90 was 280 bp). The length statistics of spliced transcripts
and unigenes were shown in Additional file 1: Table S2.
Annotation of gene function and CDS prediction
In order to assign accurate annotation information to
unigenes, multiple databases were interrogated including;
the NCBI database Non-redundant protein sequences
(Nr), the manually annotated and curated protein sequence
database (Swiss Prot), NCBI nucleotide sequences (Nt),
Protein Family (Pfam), Clusters of Orthologous Groups
of proteins (COG), Gene Ontology (GO) and Kyoto
Encyclopedia of Genes and Genomes Ortholog database
(KO). Annotation results of unigenes are shown in Table 1.
GO is a classification system to describe the properties
of the organism genes and their products, including Bio-
logical Process, Cellular Component and Molecular
Function [43]. Through alignment of GO databases,
26,692 unigenes were annotated to 57 terms of GO clas-
sification (Figure 3). Among Biological Process, ‘immune
Figure 2 The RIN and IRN content changes of Uncaria capsule from the fallen petal to yellow maturity (A) and biomorph of the sample
point 1,3,5 (B, C, D).
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genes, ‘response to stimulus [GO:0050896]’ was annotated
with 6328 unigenes, ‘metabolic process [GO:0008152]’ was
annotated with 15636 unigenes.
KOG is a classification system based on orthologous
genes. Orthologous genes have the same function and
common ancestor. 11,150 unigenes were annotated to 26
groups by KOG database (Figure 4). (R) General Func-
tional Prediction Only annotated 1869 unigenes at most,
and (X) Unnamed protein annotated 2 unigenes at least.
(G) Carbohydrate metabolism and transport was annotated
with 607 unigenes, (V) Defense mechanisms was anno-
tated with 113 unigenes (Figure 4).Table 1 Annotation result statistics between unigenes
and databases







KO 12,256 22.07KO is a network diagram of cell metabolic pathways,
including metabolism, genetic information processing, envir-
onmental information processing, cellular processes, organ-
ismal systems and human diseases. In this study, 12,256
unigenes were annotated by alignment with the KO data-
base. Among them; 4,326 unigenes were annotated to
Metabolism (35.30% of the total), 660 to Environmental
Information Processing (5.39%), 2,060 to Genetic Informa-
tion Processing (16.80%), 1,340 to Organismal Systems
(10.93%), 955 to Cellular Processes (7.79%). According to
the KO annotation, removing unigenes associated with the
Human Diseases, the remaining 8,745 unigenes (15.75% of
all unigenes) were classified to 31 KEGG pathways (Figure 5).
Among them; 269 were annotated to Metabolism of terpe-
noids and polyketides pathway, 74 unigenes involved in
Terpenoid backbone biosynthesis [PATHWAY: ko00900],
17 unigenes involved in Monoterpenoid biosynthesis
[PATHWAY: ko00902], 593 unigenes were annotated to
Amino acid metabolism pathway, 54 unigenes involved in
Phenylalanine, tyrosine and tryptophan biosynthesis [PATH-
WAY: ko00400], 295 unigenes were annotated to Biosyn-
thesis of other secondary metabolites pathway, 8 unigenes
involved in Indole alkaloid biosynthesis [PATHWAY:
ko00901].
Open Reading Frame (ORF) was obtained by compar-
ing annotation results of unigenes with the different
Figure 3 Histogram of Gene Ontology classification. The results are summarized in three main categories: biological process, cellular
component and molecular function. The right y-axis indicates the number of genes in a category. The left y-axis indicates the percentage of a
specific category of genes in that main category.
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ing Sequence (CDS) according to the standard codon table
[38]. If the results from different databases were contra-
dictory, priority was given to Nr, Swiss-prot and KEGG
GENES respectively. The unigenes that failed to match the
database information the predicted protein CDS was de-
termined using estscan software [44]. The CDS of 28,611
unigenes (51.52% of all unigenes) could be predicted using
the annotation databases whereas 16,566 unigenes (29.84%
of all unigenes) CDS predictions were made using estscan
software.
Genes involved in the biosynthesis of TIAs
TIAs biosynthesis involves three upstream metabolic
pathways, including MEP pathway, iridoid glycosides
pathway and shikimate pathway [45]. Secologanin is a
natural active substance and iridoid glycoside product of
TIAs biosynthetic precursor, but its synthesis process is
not yet understood. Another precursor tryptamine; is
generated by tryptophan using the shikimate pathway by
catalysis with TDC. TDC is communication node be-
tween primary metabolism and secondary metabolism.
Unigenes annotated by comparison with the Nr database
comparison that could encode enzymes related the
above pathways are listed in Additional file 1: Table S3.
All putative oxidoreductases that could represent genes
involved in the late steps in RIN and IRN synthesis are
listed in Additional file 1: Table S4 (A-C).
The MEP pathway is branch of Terpenoid backbone bio-
synthesis [PATHWAY: ko00900] and the iridoid glycosides
pathway is branch of Monoterpenoid biosynthesis [PATH-
WAY: ko00902], The product of phenylalanine, tyrosine
and tryptophan biosynthesis [PATHWAY: ko00400] enters
indole alkaloid biosynthesis [PATHWAY: ko00901] viaTDC and STR. Putative unigenes associated with TIAs
synthesis were annotated by KO database (in Additional
file 1: Table S5). The Uncaria capsule transcriptome data
contained all genes encoding every enzyme of the MEP
pathway and shikimate pathway. However, there are defi-
ciencies associated with the databases as the Monoterpe-
noid biosynthesis [PATHWAY: ko00902] in KO is only
aligned to myrcene/ocimene synthase (EC 4.2.3.15). In the
KEGG pathway, TDC belongs to indole alkaloid biosyn-
thesis [PATHWAY: ko00901], which is only aligned to
STR, not aligned to the TDC. The reason may be few stud-
ies were conducted with TIAs biosynthesis, and reference
data was insufficient.
Capsule DGE analysis at different periods
DGE sequencing analysis of capsule 1, capsule 2 and
capsule 3 was performed by Illumina HiSeq™ 2000 se-
quencing platforms, respectively. Capsule 1 produced
9,270,290 clean reads, capsule 2 produced 13,298,879
clean reads, and capsule 3 produced 15,331,847 clean
reads. The clean reads of the samples were mapped to
the reference sequence derived from our Uncaria tran-
scriptome data, and obtained from the annotation infor-
mation of each sample using RSEM software [46]. Total
mapped reads were capsule 1 8,529,453 (92%), capsule 2
12,258,147 (92%), and capsule 3 14,047,840 (92%) with
approximately 47,000 unigenes annotated in each sam-
ple. To estimate the level of gene expression the reads
count were transformed into Reads Per Kilo bases per
Million mapped Reads (RPKM) [47]. RPKM is the num-
ber of reads per million reads from one gene per thou-
sand bases, considering the effect of sequence length
and depth of RNA-seq process on the reads count. The
size of RPKM value therefore reflects the abundance of
Figure 4 Histogram of unigene KOG classification. The x-axis indicates 26 groups of KOG. The y-axis indicates the percentage of the number
of genes annotation under the group in the total number of genes annotation.
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threshold of significant gene expression. The density
distribution of RPKM can test gene expression profiles
of samples; comparison chart of gene expression profiles
among three samples was showed in Figure 6. Among
them, the common genes of three samples reached
38,592, characteristic genes of capsule 1 were 1,687,
characteristic genes of capsule 2 were 1,901 and charac-
teristic genes of capsule 3 were 1,986.
Analysis of differentially expressed genes
Read count data was used to analyze the difference of
gene expression. Since only one biological samples was
sequenced, in order to avoid possible high false positive
rates we first used trimmed mean of M values (TMM)
to standardize data processing [48], then took advantageof DEGseq to analyze differentially expressed genes;
the analysis conditions were qvalue <0.005 & log2 (fold-
change) >1 [49-51]. There were 1,488 differentially
expressed genes identified between capsule 2 and
capsule 1, with 803 genes were up-regulated and 685
genes were down-regulated; 1,343 differentially expressed
genes between capsule 3 and capsule 1, 749 genes were
up-regulated and 549 genes were down-regulated; 1,779
differentially expressed genes in capsule 3 vs capsule 2, with
865 genes were up-regulated and 914 genes were down-
regulated. Comparison between differentially expressed
genes between the three samples is shown in Figure 7.
Capsule 3 vs capsule 2 comparisons had the most spe-
cific differentially expressed genes. Interestingly, capsule
3 vs capsule 2 and capsule 2 vs capsule 1 had 748 com-
mon differentially expressed genes, capsule 3 vs capsule
Figure 5 Functional classification and pathway assignment of unigenes by KEGG. The results are summarized in five main categories:
A, Cellular Processes; B, Environmental Information Processing; C, Genetic Information Processing; D, Metabolism; E, Organismal Systems. The
y-axis indicates the name of the KEGG metabolic pathways. The x-axis indicates the percentage of the number of genes annotation under the
pathway in the total number of genes annotation.
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tially expressed genes, the two were very close.
Differentially expressed genes of from the DGE ana-
lysis were further analyzed using GO and KEGG enrich-
ment in order to determine their potential function and
within a metabolic pathway. GO enrichment classifica-
tion using GOseq [52]. GO classification of differentially
expressed genes between the different capsule stages is
showed in Additional file 2: Figure S3 (A-C). 419 differ-
entially expressed genes of capsule 2 vs capsule 1 were
classified into the biological process, and 133 genes were
identified as involved in oxidation-reduction process
[GO: 0055114]. 703 genes were classified into cellular
component. 903 genes were classified into molecular
function, 903 genes involved in catalytic activity
[GO:0003824], 137 genes involved in oxidoreductase
activity [GO: 0016491]. 588 genes among differentially
expressed genes of capsule 3 vs capsule 1 were classified
into the biological process, 226 genes involved in
oxidation-reduction process [GO: 0055114]. 507 genes
were classified into cellular component, 765 genes wereclassified into molecular function, 240 genes participated
in oxidoreductase activity [GO: 0016491]. 657 genes among
differentially expressed genes of capsule 3 vs capsule 2
were classified into the biological process, 255 genes
involved in oxidation-reduction process [GO: 0055114].
1301 genes were classified into cellular component, 841
genes were classified into molecular function, 272 genes
participated in oxidoreductase activity [GO: 0016491].
KEGG enrichment classification (hypergeometric test)
was used to identify significant enrichment pathways of
differentially expressed genes between the different stages of
Uncaria capsule development using a False Discovery Rate
(FDR) ≤0.05. Flavonoid biosynthesis [PATHWAY: ko00941],
phenylpropanoid biosynthesis [PATHWAY: ko00940],
phenylalanine metabolism [PATHWAY: ko00360] and bio-
synthesis of secondary metabolites [PATHWAY: ko01110]
were significantly enriched pathways among the differen-
tially expressed genes between the capsule stages. Indole
alkaloid biosynthesis [PATHWAY:ko00901] was enriched
in capsule 3 vs capsule 2, but did not reach significant level
(FDR ≤0.05) [in Additional file 2: Figure S4 (A-C)].
Figure 6 Capsule RPKM density distribution at different periods. The y-axis indicates the density values of log10 (RPKM). The x-axis indicates
the log10(RPKM) values of genes. Red, green and blue represent Capsule 1, Capsule 2 and Capsule 3 respectively.
Figure 7 Venn diagram of differentially expressed genes. The
sum of the numbers in each large circle represents total number of
differentially expressed genes between combinations, the overlap
part of the circles represents common differentially expressed genes
between combinations.
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involved in TIA biosynthesis
There were 68 unigenes that may be involved in the TIA
biosynthesis due to their homology to genes known to
be involved in TIA from other species by NCBI Nr
comparisons [53]. To narrow down this list we looked
for genes that showed expression profiles consistent with
changes in RIN and IRN content during capsule devel-
opment. As previously mentioned RIN and IRN content
is strongly elevated between capsule 1 and capsule 2,
then decreased significantly between capsule 2 and
capsule 3. RIN and IRN content is also lower in capsule
3 than that present in capsule 1. 17 of the putative TIAs
biosynthesis genes showed significantly up or down-
regulated expression (in Additional file 1: Table S6).
However, only ten genes had expression profiles either
similar or inverse to RIN and IRN accumulation in at
least 2 stages. Anthranilate synthase (AS; EC 4.1.3.27)
(comp12708_c0) and loganin acid methyltransferase
(LAMT; EC 2.1.1.50) (comp33316_c0) expression pro-
files matched of the direction of RIN and IRN content
change, whereas SLS (comp35216_c0) had the inverse
expression profiles. The expression profiles of TDC
(comp34949_c0), G10H (comp33830_c0) and STR
(comp16908_c0 and comp38465_c1) had two phases
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unigenes of KO annotation involved in the synthesis of TIAs
were based on enzymes of KEGG pathway. DGE analysis
found that 11 unigenes showed significantly up/down-regu-
lated expression changes (in Additional file 1: Table S7). AS
(comp12708_c0) expression changes with direction of RIN
and IRN content change was consistent. The up/down regu-
lated expression changes of 3-dehydroquinate dehydratase/
shikimate dehydrogenase (EC 4.2.1.10) (comp22817_c0) and
STR (comp16908_c0) with direction of RIN and IRN
content change, two phases were consistent.
Analysis of putative genes involved in the late steps of
RIN and IRN biosynthesis
Enzymes classes putatively involved of biosynthesis of
RIN and IRN include oxidoreductase, transferase, and
isomerase. CYP450 is one of the oldest protein families,
has catalytic oxidation function of carbon-carbon bond,
alkyl hydroxylation and hydroxyl oxidation, and plays an
important role in plant secondary metabolites synthesis
process [54-57]. Oxidoreductases involved in RIN and
IRN synthesis are therefore likely to come from the
CYP450 family. There are 30 varieties of methyltransfer-
ase but only o-methyl transferase is likely to be involved
in RIN and IRN [58,59]. Isomerase are relatively un-
known, however isomers conversion between RIN and
IRN could be realized through enzyme catalysis, as nat-
ural transformation of the chemical equilibrium is likely
to be small.
From the Uncaria transcriptome data, a total of 193
CYP450, 280 methyltransferase and 144 isomerase uni-
genes were identified. DGE analysis showed 29 CYP450s
were significantly up/down-regulated during capsule
development (in Additional file 1: Table S8A). Only the
expression of 1 unigene (comp28593_c0) matched changes
in RIN and IRN content. The expression profiles of 9
unigenes (comp21921_c0, comp26673_c0, comp30485_c0,
comp31075_c0, comp32966_c0, comp34791_c1, comp35950_c0,
comp37580_c0 and comp38378_c0) had similar to RIN
and IRN content in two stages. 21 methyltransferase uni-
genes possessed significantly differential expression in the
process of capsule development (in Additional file 1: Table
S8 B). 1 unigene (comp33316_c0) expression profile was
consistent to RIN and IRN content. Whereas, the expres-
sion profile of 6 unigenes (comp12388_c0, comp29880_c0,
comp34948_c0, comp36199_c0, comp36942_c0, and
comp41847_c0) where similar to RIN and IRN content
in two stages. 12 unigenes putatively encoding isomer-
ases had significantly altered expression in the process
of capsule RIN and IRN content change (in Additional
file 1: Table S8C), with 3 unigenes (comp22426_c0,
comp28178_c0 and comp38594_c0) showing changes
consistent with the TIAs RIN and IRN content in two
stages.STR is a starting point and key enzyme of TIAs
synthesis involved in the early part of TIAs synthesis.
STR expression will affect the metabolic activities of the
downstream branch. The gene expression profiles of
TIAs downstream branch are expected to be similar to
the expression profiles of STR. The gene expression
profiles not only include up/down-regulated expression,
but also include gene expression variation and amplitude
from each stage of capsule 1→ capsule 2→ capsule 3.
Expression profiles of CYP450, methyltransferase and
isomerase hierarchically clustered with that of STR
(STRNr, comp16908_c0 and comp38465_c1; STRKO,
comp16908_c0 and comp36585_c0) (shown in Figures 8
and 9). Ten candidate genes were found to cluster
closely with STR (correlation >0.99). The candidate
genes of CYP450 had 4 unigenes (comp31075_c0,
comp28593_c0, comp34791_c1 and comp26673_c0);
candidate genes of methyltransferase had 3 unigenes
(comp31161_c0, comp33316_c0 and comp34948_c0)
and candidate genes of isomerase had 3 unigenes
(comp22426_c0, comp38594_c0 and comp28178_c0).
Through the alignment of transcriptome database, the
candidate unigene sequences and amino acid sequences
of “late step genes” of RIN and IRN biosynthesis were
obtained and showed in Additional file 1: Table S9.
Quantitative PCR analysis of candidate TIA biosynthesis
genes
Quantitative PCR analysis was performed on 13 selected
genes from CYP450, methyltransferase, isomerases and
STR functional categories putatively involved in TIA
biosynthesis of Uncaria. The relative expression changes
of the candidate genes are shown in Figure 10. Generally
during the developmental process of capsule 1 to capsule
2, and capsule 2 to capsule 3 growth, the expression pro-
files of the genes assayed show highest gene expression
at the capsule 2 stage, and lowest gene expression at
capsule 3, mirroring the measured RIN and IRN content
profiles, and confirming the DGE expression data. The
STR genes (comp16908_c0, and comp38465_c1) how-
ever showed only marginal increases at capsule 2 stage.
The relative expression of one of the CYP450 genes
(comp26673_c0) was inverse to the expected expression,
with lowest expression at capsule 2 and then increasing
at capsule 3 (Figure 10 and Additional file 1: Table S8).
Discussion
The medicinal parts of Uncaria are its “stem and stem
hook” and the effective pharmacological constituents are
RIN and IRN. In Uncaria plants, if a branch has a
capsule, then there will be no stem hook. A branch with
a stem hook growing on it, will not have flowers nor
capsules next to it. In such case, there are two kinds of
leaves and stems, one is the twig containing the capsule
Figure 8 Expression profiles clustering of CYP450, methyltransferase and isomerase genes from A to C respectively at three different
capsule developmental stages. Hierarchical clustering of expression data for 29 candidate CYP450 genes, 21 candidate methyltransferase genes
and 12 candidate isomerase genes respectively using STRNr as reference profiles. Expression ratios are expressed as Log 10 values.
Figure 9 Expression profiles clustering of CYP450, methyltransferase and isomerase genes from A to C respectively at three different
capsule developmental stages. Hierarchical clustering of expression data for 29 candidate CYP450 genes, 21 candidate methyltransferase genes
and 12 candidate isomerase genes respectively using STRKO as reference profiles. Expression ratios are expressed as Log 10 values.
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Figure 10 Quantitative PCR analysis of the candidate downstream genes. A STR; B CYP450; C Methyltransferases; D Isomerases.
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http://www.biomedcentral.com/1471-2164/15/676and the other is the twig containing a stem hook. “Stem
and stem hook”, leaf, stem and capsule of Uncaria con-
tain RIN and IRN, and different parts contain different
content (data not shown). However, the difference be-
tween the RIN and IRN content of the “stem and stem
hook” and that of stem on the branch with capsule is
not significant. In addition, the serious lignification of
the stem influences the integrity of RNA. By contrast,
the difference between the RIN and IRN content of leaf
on the branch with capsule and that of the leaf on the
branch with stem hook is significant. No proteins related
to the biosynthesis of the two TIAs have been found
through dimensional electrophoresis analysis (data not
shown). Among all the tissues and organs, the capsule
has the highest RIN and IRN content and during the
developmental process there is an increase and then
decrease in the accumulation of the RIN and IRN. These
changes in RIN and IRN content in the capsule reflect
different rates of synthesis and provides a means for
identifying candidate genes involved in the biosynthesis
of RIN and IRN through analyzing the gene expression
profiles [60].
Next generation sequencing technology (NGS) offers a
shortcut for research on functional genomics, compara-
tive genomics [61-63] and genetic analysis [64] of non-
model plants. With the progress of NGS, and the
increase of sequencing throughput, improvements in
accuracy, and decreased costs, enable this technology tobe broadly applied to various research areas [65,66].
There is little to no genome information of Uncaria or
the related species. Therefore sequencing RNA using
NGS from a specific period of plant development or
treatment provides the information necessary for de
novo assembly of the transcriptome; generating a refer-
ence transcriptome sequence for non model plants that
can provide the basis for finding genes associated with
particular important functions [67-69]. DGE can quickly
and thoroughly analyze the gene expression under a
variety of tissues and conditions [70]. DGE however
requires a reference sequence to align the relative small
read lengths. Combining DGE with an RNA-sequencing
generated reference transcriptome provides an excellent
combination for analysis of non model plant species.
Confirmation of the expression profiles of a subset of
genes identified DGE using qPCR indicates the accuracy
of this method for quickly identifying candidates based
on expression profiles.
Predicting the biosynthesis pathway of RIN and IRN
lays the theoretical foundation for the regulation of the
RIN and IRN accumulation as well as their metabolic
engineering research [71]. The formation of TIAs
precursor involves the shikimate pathway of tryptophan
metabolism and MEP pathway which are the common
pathways of terpene biosynthesis. During the comparison
and annotation of TIA like genes, we found all the encod-
ing genes of the related enzymes in the two pathways in
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http://www.biomedcentral.com/1471-2164/15/676our cDNA library. Moreover, the encoding genes of STR
which include the CYP450, methyltransferase and isomer-
ase of later biosynthetic step in RIN and IRN biosynthesis
were also found. By regulating the metabolic pathway, the
accumulation of the RIN and IRN in the plant can be
improved [72,73]. This can be started from many aspects
such as improving the TIAs biosynthesis pathway activity
and upstream shunt volume of carbon skeleton. Improve-
ment of biosynthesis pathway activity can be fulfilled
through improving the activity of the key enzyme in the
pathway [74,75]. The increase of carbon shunt volume
needs to shunt more carbon from the glycometabolism to
enter the target pathway. Additionally, weaken or cutting
off the carbon channel of non target pathways etc. The
MEP pathway exists in the plastid, the amount of which
can be increased by employing the matrilineal inheritance
feature of plastid. In this way, more carbon in the
glycometabolism will enter the RIN and IRN biosynthesis
pathway. Alternatively, increase/enhance the transporter
quantity/transport ability on the plastid membrane in-
volved in the intermediate products of the MEP pathway
of RIN and IRN biosynthesis through transformation of
the organelle. Ultimately the substrate amount of iridoid
pathway is increased. The auto-regulation mechanism of
plant biosynthetic pathways is complex and strict. Con-
struction of the vitro RIN and IRN biosynthesis pathway
using information from the related research on vinblastine
and vincristine [76-79] may provide a means of accelerat-
ing our knowledge of the pathways. The low yield of
natural active substances is one of the factors limiting the
development and utilization of Chinese medicine re-
sources. The use of engineering techniques to improve
production of natural active substance is an effective way
to solve the contradiction between supply and demand.
This study presented the pathway of RIN and IRN biosyn-
thesis, and laid the theoretical foundation for the medi-
cinal potential development of RIN and IRN. If the yield
issues of RIN and IRN are effectively solved then they will
have a wider range of applications in the treatment of
Alzheimer’s disease.
Conclusion
A combination of De novo transcriptome sequencing
and DGE analysis based on the next generation sequen-
cing technology was shown to be a powerful method for
identifying candidate genes encoding enzymes respon-
sible for the biosynthesis of novel secondary metabolites
in a non-model plant. Through this method, biosynthetic
encoding genes of Uncaria TIAs biological precursor
were found. CYP450, methyltransferase and isomerase
were selected as potential candidates involved in late
biosynthesis of RIN and IRN. The transcriptome data
from this study provides an important resource forunderstanding the formation of major bioactive constitu-
ents in the capsule extract from Uncaria.
Methods
Sample collection and preparation
Uncaria was collected from Nanning, Guangxi, China,
and identified as Uncaria rhynchophylla by Ma Xiaojun.
From blossom to ripened capsules, the capsules were
collected once every ten days and six times totally. The
collected capsules were divided into two parts. One part
was frozen in liquid nitrogen for isolation of RNA, and
stored at −80°C until use. The other part was used for
the determination of RIN and IRN content by high per-
formance liquid chromatography after drying and crush-
ing. The plant samples were stored in Plant Physiology
Laboratory of Northeast Agricultural University.
The analysis results from high performance liquid
chromatography showed a single peak curve of RIN and
IRN content changes (Figure 2A) [80]. Sampling point 3
had the highest RIN and IRN content and was desig-
nated capsule 2. Sampling point 1 (designated capsule 1)
and 5 (designated capsule 3) had the low RIN and IRN
content. RNA samples from sample point 1 (capsule 1),
3 (capsule 2) and 5 (capsule 3) were used for high-
throughput sequencing.
2 μL from each of three samples were mixed for
transcriptome sequencing. 4 μL from each of three
samples were used for expression profile sequencing.
The RNA samples from sample point 1, 3 and 5 were
named capsule 1, capsule 2 and capsule 3 in expression
profile sequencing. Representative images of sample
point 1, 3 and 5 are shown in Figure 2B,C,D.
RNA isolation, quantification and qualification
Total RNA of capsule 1, capsule 2 and capsule 3 were
isolated using the improved CTAB method [81]. RNA
degradation and contamination was monitored on 1%
agarose gels. RNA purity was checked using the Nano-
Photometer®spectrophotometer (IMPLEN, CA, USA).
RNA concentration was measured using Qubit®RNA
Assay Kit in Qubit®2.0 Flurometer (Life Technologies,
CA, USA). RNA integrity was assessed using the RNA
Nano 6000 Assay Kit of the Bioanalyzer 2100 system
(Agilent Technologies, CA, USA).
Sample preparation for sequencing
A total amount of 3 μg RNA per sample were used as
input material for the RNA sample preparations. All four
samples had RNA integrity number values above 8.0.
Sequencing libraries were generated using Illumina Tru-
Seq™RNA Sample Preparation Kit (Illumia, San Diego,
USA) following manufacturer’s recommendations and
four index codes were added to attribute sequences to
each sample. Briefly, mRNA was purified from total
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mentation was carried out using divalent cations under
elevated temperature in Illumina proprietary fragmenta-
tion buffer. First strand cDNA was synthesized using
random oligonucleotides and SuperScript II. Second
strand cDNA synthesis was subsequently performed
using DNA Polymerase I and RNase H. Remaining over-
hangs were converted into blunt ends via exonuclease/
polymerase activities and enzymes were removed. After
adenylation of 3’ ends of DNA fragments, Illumina PE
adapter oligonucleotides were ligated to prepare for
hybridization. In order to select cDNA fragments of
preferentially 200 bp in length the library fragments
were purified with AMPure XP system (Beckman
Coulter, Beverly, USA). DNA fragments with ligated
adaptor molecules on both ends were selectively enriched
using Illumina PCR Primer Cocktail in a 10 cycle PCR
reaction. Products were purified (AMPure XP system)
and quantified using the Agilent high sensitivity DNA
assay on the Agilent Bioanalyzer 2100 system.
Clustering and sequencing
The clustering of the index-coded samples was per-
formed on a cBot Cluster Generation System using Tru-
Seq PE Cluster Kit v3-cBot-HS (Illumia) according to
the manufacturer’s instructions. After cluster generation,
the library preparations were sequenced on an Illumina
Hiseq 2000 platform.
Quality control
Raw data (raw reads) of fastq format were firstly
processed through our self-written perl scripts. In this
step, clean data (clean reads) were obtained by removing
reads containing adapter, reads containing ploy-N and
low quality reads from raw data. At the same time, Q20,
Q30, GC-content and sequence duplication level of the
clean data were calculated. All the downstream analyses
were based on clean data with high quality.
Transcriptome assembly
Pair-end sequencing was performed. The left files (read
1 file) from all libraries/samples were pooled into one
big left.fq file, and right files (read 2 file) into one big
right.fq file. Transcriptome assembly was accomplished
based on the left.fq and right.fq using Trinity [41] with
min_kmer_cov set to 2 and all other parameters set
default.
Gene functional annotation
Gene function was annotated based on the following
databases: Nr (NCBI non-redundant protein sequences);
Nt (NCBI non-redundant nucleotide sequences); Pfam
(Protein family); KOG/COG (Clusters of Orthologous
Groups of proteins); Swiss-Prot (A manually annotatedand reviewed protein sequence database); KO (KEGG
Ortholog database); GO (Gene Ontology).
Reads mapping to the reference genome
Sequencing-received raw image data was transformed by
base calling into sequence data. Prior to mapping reads
to the reference database, we filtered all sequences to
remove low quality sequences. A preprocessed database
of nucleotide tag was created using our transcriptome
reference database. The clean reads of the samples were
mapped to the reference sequence of Uncaria transcrip-
tome data, and obtained from the annotation informa-
tion of each sample using RSEM software.
Quantification of gene expression level
HTSeq v0.5.3 was used to count the reads numbers
mapped to each gene. And then RPKM of each gene was
calculated based on the length of the gene and reads
count mapped to this gene. RPKM, Reads Per Kilobase
of exon model per Million mapped reads, considers the
effect of sequencing depth and gene length for the reads
count at the same time, and is currently the most
commonly used method for estimating gene expression
levels [47].
Differential expression analysis
Prior to differential gene expression analysis, for each se-
quenced library, the read counts were adjusted by edgeR
program package through one scaling normalized factor.
Differential expression analysis of two conditions was
performed using the DEGseq R package (1.12.0). The P
values were adjusted using the Benjamini & Hochberg
method [51]. Corrected P-value of 0.005 and log2 (Fold
change) of 1 were set as the threshold for significantly
differential expression.
GO and KEGG enrichment analysis of differentially
expressed genes
Gene Ontology (GO) enrichment analysis of differen-
tially expressed genes was implemented by the GOseq
R package, in which gene length bias was corrected.
GO terms with corrected P-value less than 0.05 were
considered significantly enriched by differential expressed
genes.
KEGG is a database resource for understanding high-
level functions and utilities of the biological system,
such as the cell, the organism and the ecosystem,
from molecular-level information, especially large-scale
molecular datasets generated by genome sequencing
and other high-throughput experimental technologies
(http://www.genome.jp/kegg/). We used KOBAS soft-
ware to test the statistical enrichment of differential
expression genes in KEGG pathways.
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RNA for quantitative PCR analysis was the same
samples as used for DGE. Primers were designed using
Primer 5.0, and shown in Additional file 1: Table S10.
Reverse transcription used PrimerScoript RT reagent Kit
With gDNA eraser (perfect Real Time) (TaKaRa, RR047A)
and Random 6 mers primer obtained cDNA. The standard
curve was constructed using cDNA generated 1:5 with
H2O. The cDNA was diluted in the 1:20 ratio as the
sample reaction solution.
Quantitative PCR reactions used ABI7500 quantitative
PCR, and the relative standard curve method was
adopted to analyze the relative expression of genes. This
study used SYBR® Premix Ex TaqTM II (TaKaRa,
DRR820A) kit, which reaction system was 25 μL, final
concentration of primers was 0.2 μmol · L−1, template
was 1.0 μL, ROX Reference Dye II was 0.5 μL, H2O was
used for complement system, and set up six repeats.
Negative control used 1.0 μL water instead of the
template. Reaction conditions were 95°C for 5 s in order
to activate enzyme reaction. Two step cycles were then
used; 95°C for 5 s, then 60°C for 30 s, 40 cycles; solubil-
ity curve conditions were 95°C for 15 s, 60°C for 1 min,
95°C for 30 s, 60°C for 15 s.
Availability of supporting data
The data sets supporting the results of this article are
available in the BioProject (BioProject:PRJNA222278,
PRJNA222280, PRJNA222281, PRJNA222282) repository






Additional file 1: Table S1. Summary for the Uncaria rhynchophylla
transcriptome. Table S2. The length statistics of the assembled transcripts and
unigenes. Table S3. Coding genes and CDS involved in TIAs biosynthesis by
Nr database annotation. Table S4. (A) Coding genes of cytochrome P450
protein. (B) Coding genes of methyltransferase. (C) Coding genes of
isomerase. Table S5. Encoding genes involved in TIAs biosynthesis by
KO database annotation. Table S6. RPKM and up/down-regulated
expression of encoding genes involved in TIAs biosynthesis by Nr
database annotation. Table S7. Up/down regulated expression of
encoding genes involved in TIAs biosynthesis by KO database annotation.
Table S8. (A) Differential expression analysis of cytochrome P450 genes.
(B) Differential expression analysis of methyltransferase genes. (C) Differential
expression analysis of isomerase genes. Table S9. Unigene and amino acid
sequences of RIN and IRN biosynthetic encoding genes in the late step.
Table S10. The quantitative PCR primers of candidate genes.
Additional file 2: Figure S1. Error rate distribution of Capsule
transcriptome sequencing. The x-axis indicates the nucleotide position of
reads. The y-axis indicates the single-base error rate. 1–100 bp is a first
terminal sequencing error rate distribution for the two-terminal sequencing
reads, 100–200 bp is the other terminal sequencing error rate distribution.
Figure S2. G/C content distribution. 0–100 bp is the GC content distributionof the first reads sequencing in paired-end sequencing, 100–200 bp is
the GC content distribution of the other reads sequencing.
Figure S3. (A) GO classification of differentially expressed genes in
capsule 2 vs capsule 1. (B) GO classification of differentially expressed
genes in capsule 3 vs capsule 1. (C) GO classification of differentially
expressed genes in capsule 3 vs capsule 2. Figure S4. (A) KEGG pathway
enrichment scatter diagram in capsule 2 vs capsule 1. (B) KEGG pathway
enrichment scatter diagram in capsule 3 vs capsule 1. (C) KEGG pathway
enrichment scatter diagram in capsule 3 vs capsule 2.
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